The Potential of LSD, Heroin, Marijuana and Other Controlled Substances in Brain Research
Imagine being an astronomer in a world where the telescope was banned. This effectively happened in the 1600s when, for over 100 years, the Catholic Church prohibited access to knowledge of the heavens in a vain attempt to stop scientists proving that the earth was not the center of the universe. ‘Surely similar censorship could [...]
Creativity, Madness and Drugs
San Diego—Would we have Poe’s Raven today if the tormented author had taken lithium to suppress his bipolar illness? Not likely, considering the high frequency of psychiatric illnesses among writers and artists, concluded psychiatrist Kay Jamison of Johns Hopkins Medical School speaking last week at the Society for Neuroscience annual meeting in San Diego.
Is Mindfulness Good for Everything? Maybe Not for Learning to Ride a Bike
Searching the keyword “mindfulness” on Google News turns up more than 9,000 results posted over the last few weeks. The vast majority of headlines arrive in your browser resonating with hyperbolic overtones: “Pioneering Lee School uses mindfulness for pupils to beat stress and boost exams” “How to Manage Your 40,000 Thoughts A Day and Keep [...]
Ketamine, A Darling of the Club Scene, Inspires Development of Next-Generation Antidepressants, Part 3
Recent experimental research showing that the anesthetic and club drug ketamine can relieve depression quickly has intrigued a number of major pharmaceutical companies.
Is Ketamine Right for You? Off-Label Prescriptions for Depression Pick Up in Small Clinics, [Part 2]
Dennis Hartman, a 47-year-old former business executive for an Illinois gaming company, described the diagnosis he had been given as “major depression disorder with severity of the extreme, social phobia and generalized anxiety disorder,” something he had lived with for more than 30 years.
From Club to Clinic: Physicians Push Off-Label Ketamine as Rapid Depression Treatment [Part 1]
New types of drugs for schizophrenia, depression and other psychiatric disorders are few and far between—and a number of companies have scaled back or dropped development of this class of pharmaceuticals.
Dust Bowl Days Are Here Again
The current drought started in 2012, the hottest year on record in the U.S., and has embroiled the country in the worst drought since the Dust Bowl of the 1930s
Brain's Circadian Clock Disrupted in Depressed People
Major or clinical depression seems to alter the genes that regulate sleep and waking
Serotonin Receptors Offer Clues to New Antidepressants
Long-sought specificity on the shapes of serotonin binding sites could aid in the discovery of new drugs to combat depression as well as in the study of consciousness
Researchers Take a Closer Look at the Most Common and Powerful Triggers of Depression
Certain painful experiences are more likely to precede depressive episodes than others. And some forms of loss can trigger depression more quickly than previously realized
Depression Surpasses Asthma as Top Disability Problem among U.S. and Canadian Teens
New data show an increasing contribution of mental and behavioral disorders to deterioration in the health-related quality of life among teens in the U.S. and Canada over the past two decades, and increases elsewhere around the globe
Biomarker Predicts Recovery from a Type of Depression
A new study signifies the beginning of the end of psychiatrists' guess-work in figuring out which antidepressants work best for individual patients